Status:
COMPLETED
FLT PET: A Pilot Study in Lymphoma Patients
Lead Sponsor:
The Hospital for Sick Children
Conditions:
Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Eligibility:
All Genders
1-18 years
Brief Summary
Background: Residual masses on follow-up surveillance imaging are frequently detected in paediatric patients with Hodgkin's lymphoma and non-Hodgkin's lymphoma. The residual mass may consist of inflam...
Detailed Description
This is a prospective pilot study evaluating the clinical use of FLT PET in paediatric patients with Hodgkin's lymphoma (HL) or non-Hodgkin's lymphoma (NHL). The overall objective of this trial is to ...
Eligibility Criteria
Inclusion
- SickKids Hospital patient of any gender or race
- Participants who are able to undergo imaging procedures without general anaesthesia or sedation
- Patient's or the patient's parents'/guardians' written informed consent prior to participation
- Previous FDG PET scan with at least one documented equivocal finding (i.e. SUV ≥ 2.0, but \< 3.5) and no other finding(s) that is strongly suggestive of malignancy. The lesion(s) must have a minimum size of 1 cm in diameter by any CIM in order to address the spatial resolution limitations of the PET scanner.
Exclusion
- Patients who are pregnant or nursing
- Medically unstable or critically ill
- Lack of informed consent
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04028804
Start Date
July 1 2011
End Date
December 1 2014
Last Update
July 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hospital for Sick Children
Toronto, Ontario, Canada, M5G 1X8